Fanconi's anemia cells are relatively resistant to H2O2-induced damage

Haematologica

Volumn 83, Issue 10, 1998, Pages 868-874

  Notaro, Rosario ^a   Montuori, Nunzia ^a   Di Grazia, Carmen ^a   Formisano, Salvatore ^a   Rotoli, Bruno ^a   Selleri, Carmine ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Fanconi's anemia; Hematopoietic progenitors; Oxidative stress

Indexed keywords

HYDROGEN PEROXIDE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW CELL; BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROID PRECURSOR CELL; ERYTHROPHAGOCYTOSIS; FANCONI ANEMIA; FEMALE; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; MONONUCLEAR CELL; OXIDATIVE STRESS; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; FANCONI ANEMIA; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; HYDROGEN PEROXIDE; MALE; OXIDANTS; OXIDATIVE STRESS;

EID: 0031764066     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Alter BP. Hematologic abnormalities in Fanconi anemia. Blood 1995; 85:1148-9.
2. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet 1991; 51:1-12.
3. Cervenka J, Arthur D, Yasis C. Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi anemia. Pediatrics 1981; 67:119-27.
4. Alimena G, Avvisati G, De Cuia MR, Gallo E, Novelli G, Dallapiccola B. Retrospective diagnosis of a Fanconi's anemia patient by diepoxybutane (DEB) test results in parents. Haematologica 1983; 68:97-103.
5. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 1989; 73:391-6.
6. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test [editorial]. Exp Hematol 1993; 21:731-3.
7. Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1992; 1:196-8.
8. Joenje H, Oostra AB, Wijker M, et al. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 1997; 61:940-4.
9. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 1992; 356:763-7.
10. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet 1996; 14:320-3.
11. The Fanconi anaemia/breast cancer consortium. Positional cloning of the Fanconi anaemia group A gene. Nat Genet 1996; 14:324-8.
12. Youssoufian H, Auerbach AD, Verlander PC, Steimle V, Mach B. Identification of cytosolic proteins that bind to the Fanconi anemia complementation group C polypeptide in vitro. Evidence for a multimeric complex. J Biol Chem 1995; 270:9876-82.
13. Kupfer GM, Naf D, Suliman A, Pulsipher M, D'Andrea AD. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nat Genet 1997; 17:487-90.
14. Walsh CE, Nienhuis AW, Samulski RJ, et al. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 1994; 94:1440-8.
15. Fu KL, Foe JR, Joenje H, Rao KW, Liu JM, Walsh CE. Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer. Blood 1997; 90:3296-303.
16. Liu JM, Young NS, Walsh CE, et al. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients. Hum Gene Ther 1997; 8:1715-30.
17. Saito H, Hammond AT, Moses RE. Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells. Mutat Res 1993; 294:255-62.
18. Kubbies M, Schindler D, Hoehn H, Schinzel A, Rabinovitch PS. Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent endomitosis in Fanconi anemia cells. Am J Hum Genet 1985; 37:1022-30.
19. Poot M, Gross O, Epe B, Pflaum M, Hoehn H. Cell cycle defect in connection with oxygen and iron sensitivity in Fanconi anemia lymphoblastoid cells. Exp Cell Res 1996; 222:262-8.
20. Joenje H, Eriksson AW, Frants RR, Arwert F, Houwen B. Erythrocyte superoxide-dismutase deficiency in Fanconi's anaemia. Lancet 1978; 1:204.
21. Mavelli I, Ciriolo MR, Rotilio G, De Sole P, Castorino M, Stabile A. Superoxide dismutase, glutathione peroxidase and catalase in oxidative hemolysis. A study of Fanconi's anemia erythrocytes. Biochem Biophys Res Commun 1982; 106:286-90.
22. Dallapiccola B, Porfirio B, Mokini V, Alimena G, Isacchi G, Gandini E. Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes. Hum Genet 1985; 69:62-5.
23. Gille JJP, Wortelboer HM, Joenje H. Antioxidant status of Fanconi anemia fibroblasts. Hum Genet 1987; 77:28-31.
24. 2-concentration-dependent inhibition of damage and additive protective effect with the hydroxyl-radical scavenger dimethyl sulphoxide. Biochem J 1995; 305:181-5.
25. Lee KH, Abe S, Yanabe Y, Matsuda I, Yoshida MC. Superoxide dismutase activity and chromosome damage in cultured chromosome instability syndrome cells. Mutat Res 1990; 244:251-6.
26. Nagasawa H, Little JB. Suppression of cytotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts. Carcinogenesis 1983; 4:795-9.
27. Liu JM, Auerbach AD, Anderson SM, Green SW, Young NS. A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia. Br J Haematol 1993; 85:406-8.
28. Degan P, Bonassi S, De Caterina M, et al. In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 1995; 16: 735-41.
29. Korkina LG, Samochatova EV, Maschan AA, Suslova TB, Cheremisina ZP, Afanas'ev IB. Release of active oxygen radicals by leukocytes of Fanconi anemia patients. J Leukoc Biol 1992; 52:357-62.
30. Takeuchi T, Morimoto K. Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency. Carcinogenesis 1993; 14:1115-20.
31. Emerit I, Levy A, Pagano G, Pinto L, Calzone R, Zatterale A. Transferable clastogenic activity in plasma from patients with Fanconi anemia. Hum Genet 1995; 96:14-20.
32. Joenje H, Gille JJP. Oxygen metabolism and chromosomal breakage in Fanconi Anemia. In: Schroeder-Kurth TM, Auerbach AD, Obe G, eds: Fanconi Anemia: clinical, cytogenetic and experimental aspects. Berlin: Springer Verlag; 1989, pp 174-82.
33. Clarke AA, Philpott NJ, Gordon-Smith EC, Rutherford TR. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br J Haematol 1997; 96:240-7.
34. Liebetrau W, Runger TM, Mehling BE, Poot M, Hoehn H. Mutagenic activity of ambient oxygen and mitomycin C in Fanconi's anaemia cells. Mutagenesis 1997; 12:69-77.
35. Schroeder-Kurth TM, Zhu TH, Hong Y, Westphal I. Variation in cellular sensitivities among Fanconi anemia patients, non-Fanconi anemia patients, their parents and siblings, and control probands. in: Schroeder-Kurth TM, Auerbach AD, Obe G, eds. Fanconi anemia: clinical, cytogenetic and experimental aspects. Berlin: Springer Verlag, 1989. pp 105-36.
36. Sheiban E, Gersnon H. Recognition and sequestration of young and old erythrocytes from young and elderly human donors: in vitro studies. J Lab Clin Med 1993; 121:493-501.
37. Gordon-Smith EC, Rutherford TR. Fanconi anemia: constitutional aplastic anemia. Semin Hematol 1991; 28:104-11.
38. Alter BP, Knobloch ME, Weinberg RS. Erythropoiesis in Fanconi's anemia. Blood 1991; 78:602-8.
39. Butturini A, Gale RP. Long-term bone marrow culture in persons with Fanconi anemia and bone marrow failure. Blood 1994; 83:336-9.
40. Joenje H, Lo ten Foe JR, Oostra AB, et al. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood 1995; 86:2156-60.
41. Mocali A, Caldini R, Chevanne M, Paoletti F. Induction, effects, and quantification of sublethal oxidative stress by hydrogen peroxide on cultured human fibroblasts. Exp Cell Res 1995; 216:388-95.
42. Nosseri C, Coppola S, Ghibelli L. Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis. Exp Cell Res 1994; 212:367-73.
43. 2 in high-glucose medium. Diabetes 1995; 44:520-6.
44. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15:7-10.
45. Cumming RC, Liu JM, Youssoufian H, Buchwald M. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. Blood 1996; 88:4558-67.
46. Kruyt FA, Dijkmans LM, van den Berg TK, Joenje H. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood 1996; 87:938-48.
47. Whitney MA, Royle G, Low MJ, et al. Germ cell defects and hematopoietic hypersensitivity to gamma- interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood 1996; 88:49-58.
48. Rathbun RK, Faulkner GR, Ostroski MH, et al. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood 1997; 90:974-85.
49. Rosselli F, Ridet A, Soussi T, Duchaud E, Alapetite C, Moustacchi E. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. Oncogene 1995; 10:9-17.
50. Ridet A, Guillouf C, Duchaud E, et al. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res 1997; 57:1722-30.
51. Monti D, Macchioni S, Guido M, et al. Resistance to apoptosis in Fanconi's anaemia. An ex vivo study in peripheral blood mononuclear cells. FEBS Lett 1997; 409:365-9.
52. Kasahara Y, Iwai K, Yachie A, et al. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 1997; 89:1748-53.
53. Selleri C, Sato T, Raiola AM, Rotoli B, Young NS, Maciejewski JP. Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells. Br J Haematol 1997; 99:481-9.
54. 2. Role in cell survival following oxidant injury. J Biol Chem 1996; 271:4138-42.
55. Huot J, Houle F, Spitz DR, Landry J. HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res 1996; 56:273-9.
56. Marini M, Frabetti F, Musiani D, Franceschi C. Oxygen radicals induce stress proteins and tolerance to oxidative stress in human lymphocytes. Int J Radiat Biol 1996; 70:337-50.
57. Polla BS, Kantengwa S, Francois D, et al. Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc Natl Acad Sci USA 1996; 93:6458-63.
58. Clement MV, Stamenkovic I. Superoxide anion is a natural inhibitor of FAS-mediated cell death. Embo J 1996; 15:216-25.
59. Savoia A, Zatterale A, Del Principe D, Joenje H. Fanconi anaemia in Italy: high prevalence of complementation group A in two geographic clusters. Hum Genet 1996; 97:599-603.